Herpes zóster

1 Gnann JWJr, Whitley RJ. Clinical practice. Herpes zoster. N Engl J Med 2002;347:340-6.10.1056/NEJMcp013211 12151472

2 Kawai K, Gebremeskel BG, Acosta CJ. Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open 2014;4:e004833.10.1136/bmjopen-2014-004833 24916088

3 Donahue JG, Choo PW, Manson JE, Platt R. The incidence of herpes zoster. Arch Intern Med 1995;155:1605-9. 10.1001/archinte.1995.00430150071008 7618983ç

4 Insinga RP, Itzler RF, Pellissier JM, Saddier P, Nikas AA. The incidence of herpes zoster in a United States administrative database. J Gen Intern Med 2005;20:748-53.10.1111/j.1525-1497.2005.0150.x 16050886

5 Choo PW, Donahue JG, Manson JE, Platt R. The epidemiology of varicella and its complications. J Infect Dis 1995;172:706-12. 10.1093/infdis/172.3.706 7658062

6 Yanni EA, Ferreira G, Guennec M, etal . Burden of herpes zoster in 16 selected immunocompromised populations in England: a cohort study in the Clinical Practice Research Datalink 2000-2012. BMJ Open 2018;8:e020528.10.1136/bmjopen-2017-020528 29880565

7 Fleming DM, Cross KW, Cobb WA, Chapman RS. Gender difference in the incidence of shingles. Epidemiol Infect 2004;132:1-5. 10.1017/S0950268803001523 149795828 Schmader K, George LK, Burchett BM, Pieper CF, Hamilton JD. Racial differences in the occurrence of herpes zoster. J Infect Dis 1995;171:701-4.10.1093/infdis/171.3.701 7876622

9 Buchbinder SP, Katz MH, Hessol NA, etal . Herpes zoster and human immunodeficiency virus infection. J Infect Dis 1992;166:1153-6. 10.1093/infdis/166.5.1153 1308664

10 Alliegro MB, Dorrucci M, Pezzotti P, etal. Herpes zoster and progression to AIDS in a cohort of individuals who seroconverted to human immunodeficiency virus. Italian HIV Seroconversion Study. Clin Infect Dis 1996;23:990-5. 10.1093/clinids/23.5.990 8922791

11 Glesby MJ, Moore RD, Chaisson RE. Clinical spectrum of herpes zoster in adults infected with human immunodeficiency virus. Clin Infect Dis 1995;21:370-5.10.1093/clinids/21.2.370 8562746

12 Gupta G, Lautenbach E, Lewis JD. Incidence and risk factors for herpes zoster among patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 2006;4:1483-90.10.1016/j.cgh.2006.09.019 17162240

13 Smith JB, Fenske NA. Herpes zoster and internal malignancy. South Med J 1995;88:1089-92. 10.1097/00007611-199511000-00001 7481976

14 Brisson M, Gay NJ, Edmunds WJ, Andrews NJ. Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox. Vaccine 2002;20:2500-7. 10.1016/S0264-410X(02)00180-9 12057605

15 Kawai K, Yawn BP, Wollan P, Harpaz R. ncreasing incidence of herpes zoster over a 60-year period from a population-based study. Clin Infect Dis 2016;63:221-6.10.1093/cid/ciw296 27161774

16 Hales CM, Harpaz R, Joesoef MR, Bialek SR. Examination of links between herpes zoster incidence and childhood varicella vaccination. Ann Intern Med 2013;159:739-45.10.7326/0003-4819-159-11-201312030-00006 24297190

17 Russell ML, Schopflocher DP, Svenson L, Virani SN. Secular trends in the epidemiology of shingles in Alberta. Epidemiol Infect 2007;135:908-13.10.1017/S0950268807007893 17291380.

18 Brisson M, Edmunds WJ, Law B, etal . Epidemiology of varicella zoster virus infection in Canada and the United Kingdom. Epidemiol Infect 2001;127:305-14.10.1017/S0950268801005921 11693508

19 Toyama N, Shiraki KSociety of the Miyazaki Prefecture Dermatologists. Epidemiology of herpes zoster and its relationship to varicella in Japan: A 10-year survey of 48,388 herpes zoster cases in Miyazaki prefecture. J Med Virol 2009;81:2053-8.10.1002/jmv.21599 19856466

20 Schmader K. Herpes zoster in older adults. Clin Infect Dis 2001;32:1481-6.10.1086/320169 11317250

21 Dworkin RH, Johnson RW, Breuer J, etal . Recommendations for the management of herpes zoster. Clin Infect Dis 2007;44(Suppl 1):S1-26. 10.1086/510206 17143845

22 Katz J, Cooper EM, Walther RR, Sweeney EW, Dworkin RH. Acute pain in herpes zoster and its impact on health-related quality of life. Clin Infect Dis 2004;39:342-8.10.1086/421942 15307000

23 Roxas M. Herpes zoster and postherpetic neuralgia: diagnosis and therapeutic considerations. Altern Med Rev 2006;11:102-13.16813460

24 Gilden DH, Wright RR, Schneck SA, Gwaltney JMJr, Mahalingam R. Zoster sine herpete, a clinical variant. Ann Neurol 1994;35:530-3. 10.1002/ana.410350505 8179298

25 Gilden DH, Kleinschmidt-DeMasters BK, LaGuardia JJ, Mahalingam R, Cohrs RJ. Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med 2000;342:635-45. 10.1056/NEJM200003023420906 10699164

26 Dahl H, Marcoccia J, Linde A. Antigen detection: the method of choice in comparison with virus isolation and serology for laboratory diagnosis of herpes zoster in human immunodeficiency virus-infected patients. J Clin Microbiol 1997;35:347-9.9003593

27 Sauerbrei A, Eichhorn U, Schacke M, Wutzler P. Laboratory diagnosis of herpes zoster. J Clin Virol 1999;14:31-6. 10.1016/S1386-6532(99)00042-6 10548128

28 Opstelten W, Zaal MJ. Managing ophthalmic herpes zoster in primary care. BMJ 2005;331:147-51. 10.1136/bmj.331.7509.147 16020856

29 Harding SP, Lipton JR, Wells JC. Natural history of herpes zoster ophthalmicus: predictors of postherpetic neuralgia and ocular involvement. Br J Ophthalmol 1987;71:353-8.10.1136/bjo.71.5.353 3495293

30 Shaikh S, Ta CN. Evaluation and management of herpes zoster ophthalmicus. Am Fam Physician 2002;66:1723-30.12449270

31 Oxman MN, Levin MJ, Johnson GR, etal. Shingles Prevention Study Group. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005;352:2271-84. 10.1056/NEJMoa051016 15930418

32 Tyring S, Barbarash RA, Nahlik JE, etal. Collaborative Famciclovir Herpes Zoster Study Group. Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1995;123:89-96. 10.7326/0003-4819-123-2-199507150-00002 7778840

33 Beutner KR, Friedman DJ, Forszpaniak C, Andersen PL, Wood MJ. Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrob Agents Chemother 1995;39:1546-53. 10.1128/AAC.39.7.1546 7492102

34 Wood MJ, Kay R, Dworkin RH, Soong SJ, Whitley RJ. Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: a meta-analysis of placebo-controlled trials. Clin Infect Dis 1996;22:341-7. 10.1093/clinids/22.2.341 8838194